Not Yet Recruiting NA INTERVENTIONAL 3-arm
NCT07009808
Nalbuphine Dosing and Its Impact on Anxiety and Depression in Ectopic Pregnancy Surgery
Effects of Different Doses of Nalbuphine on Anxiety and Depression in Patients Undergoing Ectopic Pregnancy Surgery: A Prospective, Randomized, Controlled Study
Sponsor: Chengdu Jinjiang Maternity and Child Health Hospital
Conditions
Anxiety Depression Ectopic Pregnancy Nalbuphine
Interventions
Nalbuphine 0.20mg/ml(total 30 mg) Nalbuphine 0.27mg/ml(total 40 mg) Nalbuphine 0.33mg/ml(total 50 mg)
Updated 1 time since 2025 Last updated: Jun 6, 2025 Started: Jun 20, 2025 Primary completion: Oct 22, 2025 Completion: Oct 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07009808, this NA trial focuses on Anxiety and Depression and remains actively recruiting participants. Sponsored by Chengdu Jinjiang Maternity and Child Health Hospital, it has been updated 1 time since 2025, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Chengdu Jinjiang Maternity and Child Health Hospital
Data source: Chengdu Jinjiang Maternity and Child Health Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.